Blue Chip Partners, Inc. Pfizer Inc Transaction History

Blue Chip Partners, Inc.

$1.16 Billion
Q2 2025

A detailed history of Blue Chip Partners, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Blue Chip Partners, Inc. holds 8,775 shares of PFE stock, worth $240,171. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,775

Previous 8,636 1.61%

Holding current value

$240,171

Previous $218,000 2.75%

% of portfolio

0.02%

Previous 0.02%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$21.59 - $24.84 $3,001 - $3,452	139 Added 1.61%	8,775 $212,000
Q1 2025 May 15, 2025	BUY	$25.01 - $27.13 $215,986 - $234,294	8,636 New	8,636 $218,000
Q3 2024 Nov 04, 2024	SELL	$27.7 - $31.39 $25,788 - $29,224	-931 Reduced 20.48%	3,616 $104,000
Q2 2024 Jul 29, 2024	SELL	$25.26 - $29.6 $40,870 - $47,892	-1,618 Reduced 26.24%	4,547 $127,000
Q1 2024 Apr 25, 2024	SELL	$25.89 - $29.73 $8,776 - $10,078	-339 Reduced 5.21%	6,165 $171,000
Q4 2023 Feb 05, 2024	BUY	$26.13 - $33.94 $2,038 - $2,647	78 Added 1.21%	6,504 $187,000
Q3 2023 Oct 30, 2023	BUY	$32.09 - $37.51 $641 - $750	20 Added 0.31%	6,426 $213,000
Q2 2023 Aug 02, 2023	BUY	$36.12 - $41.79 $9,933 - $11,492	275 Added 4.49%	6,406 $234,000
Q1 2023 May 01, 2023	BUY	$39.39 - $51.28 $2,324 - $3,025	59 Added 0.97%	6,131 $250,000
Q4 2022 Feb 01, 2023	SELL	$41.75 - $54.5 $15,113 - $19,729	-362 Reduced 5.63%	6,072 $311,000
Q3 2022 Oct 27, 2022	BUY	$43.76 - $53.42 $9,102 - $11,111	208 Added 3.34%	6,434 $282,000
Q2 2022 Aug 01, 2022	BUY	$46.53 - $55.17 $25,684 - $30,453	552 Added 9.73%	6,226 $326,000
Q1 2022 May 04, 2022	SELL	$45.75 - $56.69 $182,222 - $225,796	-3,983 Reduced 41.24%	5,674 $294,000
Q4 2021 Feb 08, 2022	BUY	$41.32 - $61.25 $2,231 - $3,307	54 Added 0.56%	9,657 $570,000
Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $9,930 - $12,756	253 Added 2.71%	9,603 $413,000
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $1,651 - $1,871	46 Added 0.49%	9,350 $366,000
Q1 2021 May 04, 2021	SELL	$33.49 - $37.77 $6,363 - $7,176	-190 Reduced 2.0%	9,304 $337,000
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $13,956 - $17,747	417 Added 4.59%	9,494 $349,000
Q3 2020 Oct 27, 2020	BUY	$31.75 - $37.25 $2,921 - $3,427	92 Added 1.02%	9,077 $333,000
Q2 2020 Jul 30, 2020	SELL	$30.12 - $36.54 $3,945 - $4,786	-131 Reduced 1.44%	8,985 $294,000
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $116,904 - $167,031	4,325 Added 90.27%	9,116 $298,000
Q4 2019 Feb 11, 2020	SELL	$32.92 - $37.36 $15,834 - $17,970	-481 Reduced 9.12%	4,791 $188,000
Q3 2019 Oct 29, 2019	SELL	$32.49 - $42.13 $1.41 Million - $1.83 Million	-43,447 Reduced 89.18%	5,272 $189,000
Q2 2019 Jul 31, 2019	BUY	$36.98 - $41.52 $48,591 - $54,557	1,314 Added 2.77%	48,719 $2.11 Million
Q1 2019 Apr 23, 2019	BUY	$37.5 - $41.2 $26,025 - $28,592	694 Added 1.49%	47,405 $2.01 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $49,433 - $56,360	-1,285 Reduced 2.68%	46,711 $2.04 Million
Q3 2018 Oct 26, 2018	SELL	$34.47 - $41.81 $93,965 - $113,974	-2,726 Reduced 5.37%	47,996 $2.12 Million
Q2 2018 Jul 25, 2018	SELL	$32.98 - $35.16 $70,676 - $75,347	-2,143 Reduced 4.05%	50,722 $1.84 Million
Q1 2018 Apr 25, 2018	SELL	$31.91 - $37.02 $114,652 - $133,012	-3,593 Reduced 6.36%	52,865 $1.88 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $28,038 - $29,749	-843 Reduced 1.47%	56,458 $2.05 Million
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $134,788 - $148,484	-4,348 Reduced 7.05%	57,301 $2.05 Million
Q2 2017 Aug 07, 2017	BUY	N/A	61,649	61,649 $2.07 Million

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Chip Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Chip Partners, Inc. with notifications on news.

Account

Blue Chip Partners, Inc. Pfizer Inc Transaction History